These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33230229)

  • 1. Lithocholic bile acid induces apoptosis in human nephroblastoma cells: a non-selective treatment option.
    Trah J; Arand J; Oh J; Pagerols-Raluy L; Trochimiuk M; Appl B; Heidelbach H; Vincent D; Saleem MA; Reinshagen K; Mühlig AK; Boettcher M
    Sci Rep; 2020 Nov; 10(1):20349. PubMed ID: 33230229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells.
    Luu TH; Bard JM; Carbonnelle D; Chaillou C; Huvelin JM; Bobin-Dubigeon C; Nazih H
    Cell Oncol (Dordr); 2018 Feb; 41(1):13-24. PubMed ID: 28993998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells.
    Goldberg AA; Beach A; Davies GF; Harkness TA; Leblanc A; Titorenko VI
    Oncotarget; 2011 Oct; 2(10):761-82. PubMed ID: 21992775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrimer-Based Selective Proteostasis-Inhibition Strategy to Control NSCLC Growth and Progression.
    Walworth K; Bodas M; Campbell RJ; Swanson D; Sharma A; Vij N
    PLoS One; 2016; 11(7):e0158507. PubMed ID: 27434122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.
    Adachi R; Honma Y; Masuno H; Kawana K; Shimomura I; Yamada S; Makishima M
    J Lipid Res; 2005 Jan; 46(1):46-57. PubMed ID: 15489543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis and antitumor activity of lithocholic acid and its derivatives.
    He XL; Xing Y; Gu XZ; Xiao JX; Wang YY; Yi Z; Qiu WW
    Steroids; 2017 Sep; 125():54-60. PubMed ID: 28648585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness.
    Mikó E; Vida A; Kovács T; Ujlaki G; Trencsényi G; Márton J; Sári Z; Kovács P; Boratkó A; Hujber Z; Csonka T; Antal-Szalmás P; Watanabe M; Gombos I; Csoka B; Kiss B; Vígh L; Szabó J; Méhes G; Sebestyén A; Goedert JJ; Bai P
    Biochim Biophys Acta Bioenerg; 2018 Sep; 1859(9):958-974. PubMed ID: 29655782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid: a potential inducer of colon cancer stem cells.
    Farhana L; Nangia-Makker P; Arbit E; Shango K; Sarkar S; Mahmud H; Hadden T; Yu Y; Majumdar AP
    Stem Cell Res Ther; 2016 Dec; 7(1):181. PubMed ID: 27908290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithocholic acid attenuates cAMP-dependent Cl- secretion in human colonic epithelial T84 cells.
    Ao M; Domingue JC; Khan N; Javed F; Osmani K; Sarathy J; Rao MC
    Am J Physiol Cell Physiol; 2016 Jun; 310(11):C1010-23. PubMed ID: 27076617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
    Nölting S; Rentsch J; Freitag H; Detjen K; Briest F; Möbs M; Weissmann V; Siegmund B; Auernhammer CJ; Aristizabal Prada ET; Lauseker M; Grossman A; Exner S; Fischer C; Grötzinger C; Schrader J; Grabowski P;
    PLoS One; 2017; 12(8):e0182852. PubMed ID: 28800359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1/Nrf2 and NF-κB dependent mechanism in Caco-2 cells.
    Yao B; He J; Yin X; Shi Y; Wan J; Tian Z
    Toxicol Lett; 2019 Nov; 316():109-118. PubMed ID: 31472180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR.
    Wistuba W; Gnewuch C; Liebisch G; Schmitz G; Langmann T
    World J Gastroenterol; 2007 Aug; 13(31):4230-5. PubMed ID: 17696253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma.
    Eslin D; Sankpal UT; Lee C; Sutphin RM; Maliakal P; Currier E; Sholler G; Khan M; Basha R
    Mol Carcinog; 2013 May; 52(5):377-86. PubMed ID: 22213339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithocholic acid promotes rosacea-like skin inflammation via G protein-coupled bile acid receptor 1.
    Xiao W; Chen M; Peng Q; Sha K; Liu T; Xia J; Xie H; Li J; Xu S; Deng Z
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166563. PubMed ID: 36174876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithocholic acid promotes skeletal muscle regeneration through the TGR5 receptor.
    Sun L; Li F; Tan W; Zhao W; Li Y; Zhu X; Gao P; Shu G; Wang S; Jiang Q; Wang L
    Acta Biochim Biophys Sin (Shanghai); 2023 Jan; 55(1):51-61. PubMed ID: 36647725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
    Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
    Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithocholic acid inhibits dendritic cell activation by reducing intracellular glutathione via TGR5 signaling.
    Hu J; Zhang Y; Yi S; Wang C; Huang X; Pan S; Yang J; Yuan G; Tan S; Li H
    Int J Biol Sci; 2022; 18(11):4545-4559. PubMed ID: 35864954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithocholic Acid Stimulates IL-8 Expression in Human Colorectal Cancer Cells Via Activation of Erk1/2 MAPK and Suppression of STAT3 Activity.
    Nguyen TT; Lian S; Ung TT; Xia Y; Han JY; Jung YD
    J Cell Biochem; 2017 Sep; 118(9):2958-2967. PubMed ID: 28247965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
    Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
    J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-isopentenyladenosine: a potential therapeutic agent for a variety of epithelial cancers.
    Spinola M; Colombo F; Falvella FS; Dragani TA
    Int J Cancer; 2007 Jun; 120(12):2744-8. PubMed ID: 17304507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.